We previously demonstrated that the expression of IGF2BP3 was not dependent on the expression of EWS::FLI1 and did not correlate with either the proliferation rate or the sensitivity to therapeutic drugs used in EWS but rather correlated with the migratory capability of the tumor cells and the formation of metastasis [14, 15]. This evidence concerns the gene IGF2BP3 and neoplasm.